Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Second response from Hawk on Feb. licenses

Certainly walking a fine line with regard to 8K 1.01. Seems "ordinary" comes into play. Arguable, imo for any recurring money scenario to be considered ordinary course of business based on past...but "technically"...maybe.

Also in 1.01 "non-binding, as in letters of intent"... How is our MOU interpreted and what catagory would that fall?

http://library.findlaw.com/2004/Mar/...

I have spent many hours looking at licensee filings with regard to 8K 2.03 and 2.04 as well. Applied to us I would think only Lawyer fees would come into play here and if they have been fully accounted for or PDS relieves us of "direct obligation" then ...not applicable. Still hunting and will post further findings unless someone beats me to it. I've looked at CIZN,MAT,DTV,GBR,MSN and briefly at MC. Harder with the ADR's imo. joe

Share
New Message
Please login to post a reply